SOMERSET, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, has again been recognized by KLAS Research in the 2023 Best in KLAS report under the Small Practice Ambulatory EMR/PM (2–10 Physicians) category for delivering technology-enabled solutions that provide functionality, product performance, easy implementation and integration, and training for small practices.
The 2023 Best in KLAS report is a valuable resource provided by KLAS Research to the healthcare industry. The report provides insights into the priorities of small practices and the performance of major vendors in those areas. KLAS Research collected data from interviews with healthcare professionals over the past year, gaining valuable insights into the IT solutions and services used by their organizations.
CareCloud, who was also recognized in the 2022 Best in KLAS report, offers end-to-end technology-enabled revenue cycle solutions that can be customized to meet the unique needs of healthcare providers. This includes electronic health record solutions (also known as EMRs) that have achieved Office of the National Coordinator for Health Information Technology (ONC) certification and are Chrome Enterprise Recommended by Google as well as award-winning practice management (PM) solutions.
“EMR/PM solutions, combined with an effective revenue cycle management strategy, are becoming increasingly crucial in the healthcare industry. They are key in helping providers stay up-to-date with the constantly evolving healthcare landscape, which requires greater collaboration and coordination among providers,” stated Dr. Iram Fatima, CareCloud’s chief operating officer for electronic health records and digital health. “Moreover, as the demand for digital healthcare services continues to grow, EMR/PM solutions can play a vital role in helping providers offer more effective care to patients. By streamlining processes, reducing costs, and improving outcomes, these solutions are an essential tool for modern healthcare providers.”
The participants in the report praised CareCloud's platforms for their remarkable consistency, describing them as "extremely reliable." They also emphasized the importance of CareCloud's timely updates, highlighting how valuable it was for their organization to stay current with the latest features and improvements.
To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Bill Korn
Chief Financial Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.25 |
Daily Change: | -0.01 -0.79 |
Daily Volume: | 645,400 |
Market Cap: | US$20.320M |
April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 January 28, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load